LG.V - LGC Capital Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
0.0800
0.0000 (0.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.0800
Open0.0850
Bid0.0800 x 0
Ask0.0850 x 0
Day's Range0.0800 - 0.0850
52 Week Range0.0700 - 0.2450
Volume163,550
Avg. Volume548,305
Market Cap41.653M
Beta (3Y Monthly)2.27
PE Ratio (TTM)N/A
EPS (TTM)-0.0420
Earnings DateMar 12, 2019 - Mar 12, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    LGC Capital Ltd. Announces Name Change to Elixxer Ltd.

    MONTRÉAL, July 30, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) is pleased to announce that the TSX Venture Exchange (the “TSX-V”) has conditionally approved the change of name of the Corporation to Elixxer Ltd.  The name change was approved by the Corporation’s shareholders at the annual and special meeting held on May 22, 2019 (see press release dated May 23, 2019). The Corporation expects the name change to become effective at the opening of markets on Tuesday, August 6, 2019.  The Corporation will trade under the new symbol “ELXR” on the TSX-V. The Corporation’s new website will be Elixxer.com.

  • GlobeNewswire

    EU GMP Facility for EVOLUTION BNK Moves to Next Stage of Approval

    MONTREAL, July 24, 2019 -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) LGC is pleased to announce that Evolution BNK’s Italian certifying consultants Studio Sannino.

  • GlobeNewswire

    EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NEWSFLASH

    MONTRÉAL, July 22, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) is pleased to announce that it has paid the 2nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). Freia (www.freiafarmaceutici.it) was founded in 2009 and is presently the only company in Italy and one of few in Europe, to have created and are marketing hemp based pharmaceutical products approved by the Italian Ministry of Health and licensed for sale throughout the EU. It should be noted that Freia's products are currently authorized under the framework of pharmaceutical law and not subject to the evolving, provisional regulation of cannabis.

  • GlobeNewswire

    LGC Capital Ltd. Announces Change in Financial Year-End

    MONTRÉAL, July 16, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) wishes to announce that it is changing its financial year-end to December 31 from its current year-end of September 30.  As a result, LGC will file an additional interim report as at September 30, 2019 and will report audited financial results for a 15-month transition year from October 1, 2018 to December 31, 2019 (with a comparative of the 12 months ended September 30, 2018). Afterwards, LGC will revert to a customary reporting calendar based on a December 31 year-end, with fiscal quarters ending on the last day of March, June, September and December each year. LGC believes this change of financial year-end will allow it to complete the audit requirements of its investee companies with greater efficiency and will be useful to consolidate other companies in the future.

  • GlobeNewswire

    LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec

    MONTREAL, July 15, 2019 -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF)   LGC Capital Ltd. (“LGC” or the “Company”), announces that Health Canada, on July 12th, awarded.

  • GlobeNewswire

    LGC Capital, Ltd., update on Trichomed, Quebec

    MONTREAL, July 12, 2019 -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF)   LGC Capital Ltd. (“LGC” or the “Company”), has been advised that it has been served by Trichomed.

  • GlobeNewswire

    LGC Capital Ltd. Announces Amendment to Stock Option Plan

    MONTRÉAL, June 11, 2019 -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) announces that it has amended its stock option plan (the “Plan”) to increase the number of common.

  • GlobeNewswire

    LGC Capital News Release  

    There have been some confusing media reports from Italy regarding the opinion of the Supreme Court of Cassation on the sale of cannabis light and we urge caution in the interpretation of this ruling.  It is important that any interpretation is made with the full facts and this is only possible once the full opinion is published.  We have been closely monitoring progress with this case and despite reports to the contrary it seems clear that the Court sees products having no psychoactive effect as excluded from prohibition.  This is the area where EasyJoint operates, this is the assumption upon which it has always operated, and we are confident that it will continue to do so. LGC Capital is a leading cannabis investment firm with a focus on the legal global cannabis market. Through its growing portfolio of investment companies, LGC is building a transversal integrated organization of interconnected legal cannabis companies with cultivation, processing and distribution in Australia, Jamaica, Switzerland, Italy, and Canada serving domestic and export markets.

  • GlobeNewswire

    LGC Capital Ltd. Closes Financing With Arlington Capital and Retains Renmark Financial Communications Inc.

    MONTRÉAL, May 31, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) is pleased to announce that it has closed its previously announced financing with Arlington Capital and has retained the services of Renmark Financial Communications Inc. to handle its investor relations activities. “We are pleased to announce that we have selected Renmark to reinforce LGC Capital Ltd.'s profile in the financial community and enhance the visibility of our company. In consideration of the services to be provided, the monthly fees incurred by LGC Capital Ltd. will be a cash consideration of up to $8,000 CAD, starting June1st, 2019 for a period of six months ending on November 30th, 2019 and monthly thereafter.

  • GlobeNewswire

    LGC Capital Announces Closing of Investment in Italian Cannabis Producer, Evolution

    MONTREAL, May 29, 2019 -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC" or the “Corporation”) announces it has closed its previously announced transaction with 9379-1432.

  • GlobeNewswire

    LGC CAPITAL Announces Results of Annual Meeting, Appointment of New Chairman and Approval of Name Change to Elixxer Ltd.

    MONTRÉAL, May 23, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (LG.V) (LGGCF) ("LGC" or the “Corporation”) is pleased to announce the results of its annual and special meeting of shareholders (the “Meeting”) held yesterday in Montreal, Quebec.  At the Meeting, all five of the nominees listed in the Corporation’s management information circular dated April 17, 2019 were elected as directors, all with a vote of more than 92% of the shares voted in their favour.  Accordingly, the directors of LGC for the ensuing year are Mohammed Ghafari, Mazen Haddad, Rafi Hazan, David Lenigas and Ferras Zalt. At the Meeting, shareholders adopted a special resolution approving a change in the name of the Corporation to “Elixxer Ltd.” or such other name as the Corporation’s directors may determine.  The special resolution was supported by 98.94% of the votes cast at the Meeting.

  • CNW Group

    IIROC Trading Resumption - LG

    IIROC Trading Resumption - LG

  • GlobeNewswire

    LGC Capital announces that it has increased its ownership to 40.4% of Little Green Pharma in Australia

    MONTRÉAL, May 22, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (LG.V) (LGGCF) ("LGC" or the “Corporation”) announces that after much negotiation, it has successfully acquired, from a non-executive founder, additional shares in Australia’s licensed medical cannabis producer Little Green Pharma (LGP) bringing its ownership from 14.1% up to 40.4%. LGP was the first, and is currently the only, domestic cannabis company in Australia producing a locally grown medicinal cannabis medicine for patients.  LGC believes the opportunity to increase its ownership in LGP creates significant value for its shareholders and enables the Corporation to further take part in the rapidly expanding Australian medical cannabis market.

  • CNW Group

    IIROC Trading Halt - LG

    IIROC Trading Halt - LG

  • GlobeNewswire

    LGC Capital Intends to Extend Warrants

    MONTRÉAL, May 16, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (LG.V) (LGGCF) ("LGC" or the “Corporation”) announces that it will be applying to the TSX Venture Exchange (the “TSX-V”) for approval to extend the expiry date of an aggregate of 24,871,822 outstanding common share purchase warrants (the “Warrants”) that were issued in connection with a private placement which closed in December 2017, as further described in LGC’s press releases dated December 1 and December 7, 2017. Each Warrant entitles the holder thereof to purchase one common share in the capital of the Corporation at an exercise price of $0.25 per share. A total of 19,871,822 of the Warrants currently have an expiry date of June 1, 2019, and 5,000,000 of the Warrants currently have an expiry date of June 7, 2019.

  • GlobeNewswire

    LGC Capital Announces Agreement to Acquire a Significant Interest in Fully Licenced European Pharmaceutical Company, Freia Farmaceutici Srl.

    LGC Capital to acquire a significant stake in European pharmaceutical company, Freia. Freia is currently the only company in Italy, and one of few in Europe with EFSA approved hemp-based pharmaceutical products. Freia has been granted 2 patents and submitted a further 5 patent applications.

  • GlobeNewswire

    LGC Capital provides status update on private placement with Arlington Capital LP

    MONTRÉAL, May 10, 2019 -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC" or the “Corporation”) LGC CAPITAL Ltd. is providing a status update in respect of its.

  • GlobeNewswire

    LGC CAPITAL announces closing of a first tranche of its $10.4 million financing and appointment of Arlington Capital CEO, Ferras Zalt, to LGC's board of directors

    LGC Capital Ltd. (LG.V) (LGGCF) ("LGC" or the  “Corporation”) is pleased to announce that it has now closed the first tranche of its previously announced $10.4 million non-brokered private placement financing with Arlington Capital LP. The Corporation has issued a total of 80,000,000 commons shares at an issue price of $0.10 per share for gross proceeds of $8,000,000.  The shares issued to Arlington Capital are subject to a four-month hold period.  The second tranche of the private placement is expected to close shortly. LGC is also very pleased to announce that Ferras Zalt has been appointed as the Corporation’s Chairman of the Board and will formally assume the role at LGC’s upcoming annual meeting of shareholders on May 22, 2019.

  • GlobeNewswire

    LGC CAPITAL announces conditional approval of an amended private placement financing of $10,400,000 with Arlington Capital LP

    MONTRÉAL, April 25, 2019 -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC") is pleased to announce that it has obtained conditional approval from the TSX Venture.

  • GlobeNewswire

    LGC Capital Grants Stock Options

    MONTREAL, April 05, 2019 -- LGC Capital Ltd. (the “Corporation” or “LGC”) (TSXV:LG) (OTCQB:LGGCF) announces that it has granted stock options to purchase a total of 6,100,000.

  • GlobeNewswire

    LGC Capital Announces First Commercial Sales of Medical Cannabis in Jamaica From Global Canna Labs

    MONTRÉAL, April 04, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG, OTCQB: LGGCF) (“LGC”) is pleased to announce that is has been advised that Global Canna Labs has now received their formal approvals late in March from the Jamaican Cannabis Licensing Agency (CLA) to commence commercial medical cannabis sales domestically to licensed dispensaries. As of today, Global Canna Labs has now sold a total of 46.5 kilograms of dried medical cannabis products in to the local dispensaries. LGC also advises that Global Canna Labs has now planted out the majority of its 6.2 acre site in Montego Bay and expects to commence harvesting, under CLA supervision, two sectional harvests per months from various phases of crop growth and various Cannabis strains, with the first of these bi-monthly harvests scheduled for April 10.

  • PR Newswire

    LGC CAPITAL Announces New Chapter in Its Corporate Evolution With the Addition of a Highly Experienced Global Executive Team Bringing on 90 Years of British American Tobacco and Monsanto Experience

    MONTRÉAL, April 3, 2019 /PRNewswire/ -- LGC CAPITAL (LGC Capital Ltd.) (LG.V) (LGGCF) ("LGC") announces four new additions to the executive team. LGC Chief Operating Officer, Remy di Meglio, together with both John McMullen and Mazen Haddad, has assembled this team bringing over 90 year's experience with British American Tobacco and Monsanto to LGC.

  • GlobeNewswire

    LGC CAPITAL Announces new chapter in its corporate evolution with the addition of a highly experienced global Executive Team bringing on over 90 years of combined experience from British American Tobacco and Monsanto

    LGC CAPITAL announces four new additions to the executive team.  LGC Chief Operating Officer, Remy di Meglio, together with both John McMullen and Mazen Haddad, has assembled this team bringing over 90 years' experience with British American Tobacco and Monsanto to LGC.  To lead the team, Mazen Haddad will remain as Co-Chairman and take on the additional role of CEO.  John McMullen will assume the role as President and Mark Shinners of Arlington Capital will take on the role of CFO.

  • LGC CAPITAL Announces new chapter in its corporate evolution with the addition of a highly experienced global Executive Team bringing on 90 years of British American and Monsanto
    CNW Group

    LGC CAPITAL Announces new chapter in its corporate evolution with the addition of a highly experienced global Executive Team bringing on 90 years of British American and Monsanto

    LGC CAPITAL announces four new additions to the executive team.  LGC Chief Operating Officer, Remy di Meglio , together with both John McMullen and Mazen Haddad , has assembled this team bringing over 90 year's experience with British American Tobacco and Monsanto to LGC.  To lead the team, Mazen Haddad will remain as Co-Chairman and take on the additional role of CEO.  John McMullen will assume the role as President and Mark Shinners of Arlington Capital will take on the role of CFO.